9 medicines held by Grünenthal GmbH on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Moventig 12.5 mg film-coated tablets EU/1/14/962/001-003 |
Naloxegol oxalate | Grünenthal GmbH | — |
| Moventig 25 mg film-coated tablets EU/1/14/962/004-007 |
Naloxegol oxalate | Grünenthal GmbH | — |
| PecFent 100 micrograms/spray nasal spray, solution EU/1/10/644/001-002 |
Fentanyl, as citrate salt | Grünenthal GmbH | — |
| PecFent 400 micrograms/spray nasal spray, solution EU/1/10/644/003-004 |
Fentanyl, as citrate salt | Grünenthal GmbH | — |
| Qutenza 179 mg cutaneous patch EU/1/09/524/001-002 |
Capsaicin | Grünenthal GmbH | — |
| SANCUSO 3.1 mg/24 hours transdermal patch EU/1/12/766/001 |
Granisetron | Grünenthal GmbH | — |
| Transtec 35 micrograms/h Transdermal Patch PA1032/001/001 |
Buprenorphine | Grünenthal GmbH | Marketed |
| Transtec 52.5 micrograms/h Transdermal Patch PA1032/001/002 |
Buprenorphine | Grünenthal GmbH | Marketed |
| Transtec 70 micrograms/h Transdermal Patch PA1032/001/003 |
Buprenorphine | Grünenthal GmbH | Marketed |
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.